Company intelligence / Profile preview

Magnolia Medical Technologies

Seattle, Washington, United Statesmagnolia-medical.com ↗

Ownership: Private
Employees: ~99
Development stage: Commercial

Overview

Clinical studies have shown that the Steripath ISDD reduces blood culture contamination rates by up to 83–88% in peripheral venipuncture settings. The device has FDA 510(k) clearance with a specific indication to reduce blood culture contamination for sepsis testing accuracy. Multiple peer-reviewed publications support its effectiveness in reducing misdiagnosis and unnecessary antibiotic use.

Therapeutic areas: Infectious Diseases
Modalities: Device (blood and bodily fluid collection devices)Non-pharmacological therapy (diagnostic stewardship tools)Software (analytics platform for clinical data)
Industry: Consumable Medical Devices

Partnerships

Collaborations with large U.S. hospital systemsVizient Innovative Technology Supplier of the Year award recipientno major pharma/biotech partnerships disclosed

Beyond the preview

Go deeper on Magnolia Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magnolia Medical Technologies.

Explore the full profile